Home › Funds › CPP Investments › RYTM
CPP Investments position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)47.40K sh
Reported value held$5.26M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 267.00K | $12.27M | New |
| Q1 2024 | 577.00K | $25.00M | Add |
| Q2 2024 | 417.00K | $17.12M | Reduce |
| Q3 2024 | 67.00K | $3.51M | Reduce |
| Q3 2025 | 37.00K | $3.74M | New |
| Q2 2026 | 47.40K | $5.26M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RYTM
- BlackRock Inc 6.16M sh · $683.60M · Q2 2026
- Vanguard Group 6.21M sh · $664.82M · Q4 2025
- JPMorgan Chase & Co 2.65M sh · $292.18M · Q2 2026
- Goldman Sachs Group 2.13M sh · $236.11M · Q2 2026
- Geode Capital Management 1.53M sh · $170.32M · Q2 2026
- Capital Research Global Investors 1.53M sh · $170.13M · Q2 2026
- Citadel Advisors 1.31M sh · $145.36M · Q2 2026
- Morgan Stanley 1.11M sh · $123.49M · Q2 2026
- Fidelity Management & Research (FMR) 1.03M sh · $113.90M · Q2 2026
- Janus Henderson Group 918.15K sh · $79.89M · Q1 2026
- Norges Bank Investment Management 685.84K sh · $76.15M · Q2 2026
- Franklin Resources 577.03K sh · $64.07M · Q2 2026